Desmoplastic Melanoma: Symptoms, Diagnosis, Treatment & Prognosis

~Introduction

Desmoplastic melanoma is a rare and unique subtype of melanoma, a form of skin cancer that originates in melanocytes—the cells responsible for producing pigment (melanin). Unlike more common melanomas, desmoplastic melanoma behaves differently in terms of growth patterns, clinical presentation, and response to treatment. It is often more difficult to diagnose because it can resemble benign skin lesions or scar tissue.

Although it accounts for less than 4% of all melanoma cases, desmoplastic melanoma is clinically significant due to its tendency for local recurrence and its distinct pathological features. Early detection and appropriate management are crucial for improving patient outcomes.

~What Is Desmoplastic Melanoma?

Desmoplastic melanoma is characterized by the presence of dense fibrous (desmoplastic) tissue surrounding malignant melanoma cells. This fibrous stroma gives the tumor a scar-like appearance, making it harder to identify both clinically and histologically.

It is most commonly found in sun-exposed areas of the body, particularly the head and neck region. The condition primarily affects older adults and is more prevalent in individuals with a history of chronic sun exposure.

~Epidemiology and Risk Factors

Who Is at Risk?

Desmoplastic melanoma tends to affect:

• Individuals over the age of 50

• People with fair skin

• Those with a history of excessive sun exposure

• Individuals with a history of non-melanoma skin cancers

Key Risk Factors

1. Ultraviolet (UV) Radiation
   Long-term exposure to UV rays from the sun or tanning beds is the most significant risk factor.

2. Genetic Predisposition
   While less common, certain genetic mutations may increase susceptibility.

3. Previous Skin Damage
   Chronic sun damage or prior skin cancers can increase the likelihood of developing this condition.

~Causes and Pathogenesis

The exact cause of desmoplastic melanoma is not fully understood, but it is closely linked to DNA damage caused by UV radiation. This damage leads to mutations in melanocytes, causing uncontrolled growth.

Unlike other melanomas, desmoplastic melanoma often exhibits mutations in genes such as:

• NF1 (Neurofibromin 1)

• TP53

• CDKN2A

These genetic alterations contribute to tumor development and progression.

~Clinical Features and Symptoms

Appearance

Desmoplastic melanoma often presents as:

• A firm, fibrous, or scar-like lesion

• A non-pigmented (amelanotic) growth

• A slowly enlarging plaque or nodule

Common Symptoms

• Thickened or hardened skin area

• A lesion that resembles a scar but continues to grow

• Itching or tenderness (less common)

• Bleeding in advanced cases

Common Locations

• Head and neck (most frequent)

• Upper back

• Arms

Because it often lacks pigmentation, it can be mistaken for benign conditions such as scars, fibromas, or cysts.

~Types of Desmoplastic Melanoma

Desmoplastic melanoma is generally classified into two types:

1. Pure Desmoplastic Melanoma

• Composed almost entirely of desmoplastic tissue

• Lower risk of lymph node involvement

• Better prognosis

2. Mixed Desmoplastic Melanoma

• Contains both desmoplastic and conventional melanoma components

• Higher likelihood of metastasis

• More aggressive behavior

~Diagnosis

Diagnosing desmoplastic melanoma can be challenging due to its atypical appearance.

Clinical Examination

Dermatologists may use dermoscopy to evaluate suspicious lesions, but findings are often non-specific.

Biopsy

A definitive diagnosis requires a biopsy. Types include:

• Excisional biopsy (preferred)

• Incisional or punch biopsy

Histopathological Features

Under the microscope, desmoplastic melanoma shows:

• Spindle-shaped melanoma cells

• Dense collagenous stroma

• Perineural invasion (tumor cells around nerves)

Immunohistochemistry

Markers used for diagnosis include:

• S-100 protein (highly sensitive)

• SOX10

• Negative or weak staining for HMB-45 and Melan-A

~Staging

Staging is based on the same criteria used for other melanomas, primarily the AJCC (American Joint Committee on Cancer) staging system.

Key factors include:

• Tumor thickness (Breslow depth)

• Ulceration

• Lymph node involvement

• Presence of metastasis

Desmoplastic melanoma often presents with thicker tumors but has a lower rate of lymph node metastasis compared to other melanomas.

~Treatment Options

1. Surgical Excision

The primary treatment for desmoplastic melanoma is wide local excision.

• Margins of 1–2 cm are typically recommended

• Complete removal is critical to reduce recurrence

2. Sentinel Lymph Node Biopsy (SLNB)

• Less commonly positive in pure desmoplastic melanoma

• May still be recommended in mixed types

3. Radiation Therapy

Radiotherapy is often used in:

• High-risk cases

• Tumors with perineural invasion

• Recurrent disease

It helps reduce local recurrence rates.

4. Immunotherapy

Modern treatments include immune checkpoint inhibitors such as:

• PD-1 inhibitors (e.g., pembrolizumab, nivolumab)

Desmoplastic melanoma responds well to immunotherapy due to its high mutational burden.

5. Targeted Therapy

Less commonly used because typical melanoma mutations (like BRAF) are less frequent in this subtype.

~Prognosis and Survival Rate

The prognosis of desmoplastic melanoma varies depending on several factors.

Favorable Factors

• Pure desmoplastic subtype

• Early-stage detection

• Complete surgical removal

Less Favorable Factors

• Mixed subtype

• Perineural invasion

• Local recurrence

Survival Rates

• Generally similar or slightly better than other melanomas when matched by stage

• Lower risk of lymph node metastasis

• Higher risk of local recurrence

~Complications

If not treated early, desmoplastic melanoma can lead to:

• Local recurrence

• Nerve involvement causing pain or numbness

• Distant metastasis (lungs, brain, liver)

~Prevention

While not all cases can be prevented, the risk can be reduced through:

Sun Protection

• Use broad-spectrum sunscreen (SPF 30 or higher)

• Wear protective clothing

• Avoid peak sun hours

Regular Skin Checks

• Perform monthly self-examinations

• Visit a dermatologist annually

Early Detection

Look for:

• New or changing lesions

• Scar-like growths that do not heal

• Firm, non-pigmented nodules

~When to See a Doctor

Seek medical attention if you notice:

• A persistent or growing scar-like lesion

• Any unusual skin change that does not heal

• A firm lump on sun-exposed skin

Early consultation with a dermatologist can significantly improve outcomes.

~Recent Advances and Research

Research into desmoplastic melanoma is ongoing, with promising developments in:

Immunotherapy

Studies show higher response rates compared to other melanoma types due to:

• High tumor mutational burden

• Increased immune system recognition

Molecular Profiling

Advances in genetic testing are helping:

• Identify mutations

• Personalize treatment strategies

Artificial Intelligence in Diagnosis

AI-assisted tools are being developed to:

• Improve early detection

• Reduce misdiagnosis

~Living with Desmoplastic Melanoma

A diagnosis can be challenging, but patients can manage the condition effectively with proper care.

Follow-Up Care

• Regular dermatology visits

• Imaging tests if needed

• Monitoring for recurrence

Emotional Support

• Counseling or therapy

• Support groups for melanoma patients

~Conclusion

Desmoplastic melanoma is a rare but important subtype of melanoma that requires a high level of clinical suspicion for diagnosis. Its unique characteristics—such as a scar-like appearance and a tendency for local recurrence—make early detection and appropriate treatment essential.

While it may be more challenging to identify, advancements in diagnostic techniques and immunotherapy have significantly improved outcomes for patients. By practicing sun safety, performing regular skin checks, and seeking timely medical care, individuals can reduce their risk and ensure early intervention.

Understanding desmoplastic melanoma is the first step toward effective prevention, diagnosis, and treatment—ultimately leading to better patient outcomes and quality of life.